Calporta Therapeutics Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $576M

Calporta Therapeutics General Information


Developer of medicinal product designed to offer treatment of niemann-pck C disease. The company's products include selective small molecule agonists of transient receptor potential cation channel for the treatment of lysosomal storage diseases caused by mutations, enabling patients to get advanced treatment for their diseases and recover faster.

Contact Information

Ownership Status
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Corporate Office
  • 11099 North Torrey Pines Road
  • Suite 290
  • San Diego, CA 92037
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Calporta Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 13-Nov-2019 $576M 0000 00000 Completed Generating Revenue
1. Early Stage VC (Series A) 22-Jun-2015 0000 0000 000.00 Completed Startup
To view Calporta Therapeutics’s complete valuation and funding history, request access »

Calporta Therapeutics Cap Table

Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 0,000,000 00.000000 00 00.00 00.00 00 00.00 000
To view Calporta Therapeutics’s complete cap table history, request access »

Calporta Therapeutics Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Avalon Ventures Venture Capital Minority 000 0000 000000 0
GSK Corporation Minority 000 0000 000000 0
To view Calporta Therapeutics’s complete investors history, request access »

Calporta Therapeutics FAQs

  • When was Calporta Therapeutics founded?

    Calporta Therapeutics was founded in 2015.

  • Who is the founder of Calporta Therapeutics?

    Sergio Duron Ph.D and Haoxing Xu Ph.D are the founders of Calporta Therapeutics.

  • Where is Calporta Therapeutics headquartered?

    Calporta Therapeutics is headquartered in San Diego, CA.

  • What industry is Calporta Therapeutics in?

    Calporta Therapeutics’s primary industry is Drug Discovery.

  • Is Calporta Therapeutics a private or public company?

    Calporta Therapeutics is a Private company.

  • What is the current valuation of Calporta Therapeutics?

    The current valuation of Calporta Therapeutics is 00000.

  • What is Calporta Therapeutics’s current revenue?

    The current revenue for Calporta Therapeutics is 000000.

  • How much funding has Calporta Therapeutics raised over time?

    Calporta Therapeutics has raised $10M.

  • Who are Calporta Therapeutics’s investors?

    Avalon Ventures and GSK have invested in Calporta Therapeutics.

  • When was Calporta Therapeutics acquired?

    Calporta Therapeutics was acquired on 13-Nov-2019.

  • Who acquired Calporta Therapeutics?

    Calporta Therapeutics was acquired by Merck.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »